PALMER STEPHEN. S

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.

Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.